Average Co-Inventor Count = 14.49
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Inc. (11 from 822 patents)
2. Galapagos Nv (7 from 116 patents)
3. Abbvie S.a.r.l. (7 from 15 patents)
4. Supernus Pharmaceuticals, Inc. (3 from 80 patents)
5. Abbott Laboratories Corporation (1 from 4,179 patents)
6. Abbvie Bahamas Limited (6 patents)
7. Abbvie Overseas Sarl (5 patents)
22 patents:
1. 11077114 - Stabilized formulations of CNS compounds
2. 10647717 - N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
3. 10259810 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
4. 10149853 - Stabilized formulations of CNS compounds
5. 10130622 - Compounds for treatment of cystic fibrosis
6. 10118916 - Modulators of cystic fibrosis transmembrane conductance regulator protein
7. 10039754 - Anti-viral compounds
8. 10028937 - Anti-viral compounds
9. 9890158 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
10. 9840513 - Substituted tricyclics and method of use
11. 9796711 - [object Object]
12. 9586978 - Anti-viral compounds
13. 9278922 - Anti-viral compounds
14. 9249138 - Anti-viral compounds
15. 9006387 - Anti-viral compounds